Celon Pharma Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,112	305	1,425	789	716	1,691
Market Cap Growth	-14.32%	-78.57%	80.47%	10.32%	-57.68%	-7.35%
Enterprise Value	1,157	304.28	1,366	700.38	577.71	1,478
Last Close Price	20.65	20.35	26.45	15.46	14.02	33.15
Forward PE	337.01	24.15	35.84	72.92	72.92	72.92
PB Ratio	2.10	0.84	3.20	1.77	1.49	3.05
P/TBV Ratio	3.16	3.11	3.26	1.83	1.56	2.95
P/FCF Ratio	-	-	-	-	-	650.25
P/OCF Ratio	36.50	7.04	-	-	-	38.47
EV/EBITDA Ratio	54.01	14.21	90.80	-	-	47.85
EV/FCF Ratio	-	-	-	-	-	568.47
Debt / Equity Ratio	0.03	0.03	0.02	0.01	0.02	0.02
Debt / EBITDA Ratio	0.89	0.89	1.13	-	-	0.48
Debt / FCF Ratio	-	-	-	-	-	5.74
Net Debt / Equity Ratio	0.00	0.00	-0.13	-0.20	-0.29	-0.38
Net Debt / EBITDA Ratio	-0.04	-0.04	-3.86	-	-	-6.88
Net Debt / FCF Ratio	0.09	0.09	1.25	-	-	-81.78
Quick Ratio	1.14	1.14	1.90	1.89	1.70	2.95
Current Ratio	1.62	1.62	2.40	2.20	2.04	3.23
Return on Equity (ROE)	-19.63%	-19.63%	-7.73%	0.00%	0.00%	-2.58%
Return on Assets (ROA)	-9.04%	-9.04%	-5.65%	0.00%	0.00%	-1.30%
Return on Invested Capital (ROIC)	-12.50%	-12.08%	-8.46%	0.00%	0.00%	-2.41%
Return on Capital Employed (ROCE)	-5.71%	-5.71%	-7.67%	0.00%	0.00%	-2.01%
FCF Yield	-	-	-	0.00%	0.00%	0.15%
Dividend Yield	-	0.00%	0.29%	0.00%	0.00%	0.20%
Payout Ratio	-	0.00%	-11.86%	-	-	-27.14%
Buyback Yield / Dilution	2.29%	1.35%	-5.51%	-0.05%	-9.29%	-3.74%
Total Shareholder Return	2.29%	1.35%	-5.22%	-0.05%	-9.29%	-3.54%